Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Millennium, Xoma deal

The companies restructured the financial portion of their 2001 deal to develop

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE